RSCF (Reflect Scientific) ROE % Adjusted to Book Value: 3.51% (As of Sep. 2025)


What is Reflect Scientific ROE % Adjusted to Book Value?

Reflect Scientific RSCF ROE % Adjusted to Book Value is 3.51% as of Sep. 2025. The stock has 4 warning signs investors should review.

Reflect Scientific's ROE % for the quarter that ended in Sep. 2025 was 7.69%. Reflect Scientific's PB Ratio for the quarter that ended in Sep. 2025 was 2.19. Reflect Scientific's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2025 was 3.51%.

Reflect Scientific ROE % Adjusted to Book Value Related Terms

Reflect Scientific ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Reflect Scientific's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Reflect Scientific ROE % Adjusted to Book Value Chart

Reflect Scientific Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.25 2.09 12.01 1.75 -7.25

Reflect Scientific Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Jun25 Sep25
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.21 9.98 9.74 -0.49 3.51

RSCF vs GCTK, CBSC, NXGL: ROE % Adjusted to Book Value Comparison

For the Medical Instruments & Supplies subindustry, Reflect Scientific's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Reflect Scientific ROE % Adjusted to Book Value vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Reflect Scientific's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Reflect Scientific's ROE % Adjusted to Book Value falls into.


Reflect Scientific ROE % Adjusted to Book Value Calculation

Reflect Scientific's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-21.91% / 3.02
=-7.25%

Reflect Scientific's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=7.69% / 2.19
=3.51%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 3.51% mean?
Reflect Scientific (RSCF) has a ROE % Adjusted to Book Value of 3.51% as of Sep. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Reflect Scientific and its competitors.
Is Reflect Scientific's ROE % Adjusted to Book Value too high?
Reflect Scientific's current ROE % Adjusted to Book Value is 3.51%.
How does Reflect Scientific's ROE % Adjusted to Book Value compare to GCTK and CBSC?
Reflect Scientific's ROE % Adjusted to Book Value of 3.51% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Devices & Instruments company?
A good ROE % Adjusted to Book Value depends on the Medical Devices & Instruments industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Reflect Scientific and its competitors. Reflect Scientific's current ROE % Adjusted to Book Value is 3.51%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Reflect Scientific stock overvalued right now?
Reflect Scientific (RSCF) has a current ROE % Adjusted to Book Value of 3.51%. The current ROE % Adjusted to Book Value is 3.51%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Reflect Scientific (RSCF), the current ROE % Adjusted to Book Value is 3.51% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Reflect Scientific Business Description

Address 1266 South 1380 West, Orem, UT, USA, 84058
Reflect Scientific Inc is engaged in the manufacture and distribution of products targeted at the life science market. The group's customers include hospitals, diagnostic laboratories, pharmaceutical and biotech companies, cold chain management, universities, government and private sector research facilities, and chemical and industrial companies. Its growing product portfolio includes ultra-low temperature freezers, blast freezers, solvent chillers, and refrigerated transportation in addition to supplying OEM products to the life sciences industry. The group's products are Cryometrix, GCFerrules, and Visacon. It recognizes revenue from the sale of scientific equipment for the life sciences and manufacturing industries.